Pariser, D.; Sussman, J.; Martin, B.; Ackerman, L.; Kraffert, C.; Jarell, A. Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients With Stage I-III Cutaneous Melanoma . J of Skin 2024, 8, s386.